Competition, not need, drives hospital cardiac care investment
U.S. hospitals spent up to $4 billion adding angioplasty services over a four year period, but the new services did little to improve access to timely medical care, says a study published Tuesday in the journal Circulation. Between 2004 to 2008, some 251 hospitals added the invasive and often life-saving cardiac care, but researchers found that the new programs were mainly built near existing ones in competitive healthcare markets, rather than where the need for the services was greatest. The percent of the U.S. population with timely access to angioplasty—a drive time of under one hour—improved by less than 2 percent during the study period. At the same time, the number of hospital-based cardiac labs and clinics increased by 16 percent, the study found. The millions of dollars hospitals have spent adding the services led to higher insurance premiums for everyone, researchers concluded.
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- CA Powers Up $80M HIE to 'Create Value in the Data'
- TJC Warns Hospitals of Deadly Medical Tubing Mistakes
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Carondelet to Pay $35M to Settle Fraud Allegations